Evernest Financial Advisors LLC grew its holdings in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 3.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,559 shares of the healthcare conglomerate’s stock after purchasing an additional 128 shares during the quarter. Evernest Financial Advisors LLC’s holdings in UnitedHealth Group were worth $1,800,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds also recently modified their holdings of the company. International Assets Investment Management LLC increased its position in shares of UnitedHealth Group by 78,814.4% during the third quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock worth $3,096,896,000 after acquiring an additional 5,290,025 shares in the last quarter. Accredited Investors Inc. increased its stake in UnitedHealth Group by 9,235.4% in the 3rd quarter. Accredited Investors Inc. now owns 784,924 shares of the healthcare conglomerate’s stock valued at $458,929,000 after buying an additional 776,516 shares during the last quarter. Raymond James & Associates grew its holdings in shares of UnitedHealth Group by 33.1% in the third quarter. Raymond James & Associates now owns 2,361,396 shares of the healthcare conglomerate’s stock valued at $1,380,661,000 after acquiring an additional 587,088 shares in the last quarter. Caisse DE Depot ET Placement DU Quebec boosted its position in UnitedHealth Group by 129.7% in the third quarter. Caisse DE Depot ET Placement DU Quebec now owns 1,029,540 shares of the healthcare conglomerate’s stock worth $601,951,000 after purchasing an additional 581,324 shares during the last quarter. Finally, State Street Corp raised its position in UnitedHealth Group by 1.3% in the third quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate’s stock worth $26,626,387,000 after acquiring an additional 563,554 shares during the period. Institutional investors own 87.86% of the company’s stock.
UnitedHealth Group Stock Performance
Shares of NYSE:UNH opened at $545.29 on Friday. The company has a 50-day moving average price of $538.18 and a 200-day moving average price of $565.09. The company has a market cap of $501.82 billion, a price-to-earnings ratio of 35.18, a price-to-earnings-growth ratio of 1.46 and a beta of 0.62. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73.
UnitedHealth Group Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were given a $2.10 dividend. The ex-dividend date was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.54%. UnitedHealth Group’s dividend payout ratio is currently 54.19%.
Insider Activity at UnitedHealth Group
In related news, Director Timothy Patrick Flynn bought 1,000 shares of the stock in a transaction on Friday, January 17th. The shares were acquired at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 0.33% of the stock is owned by corporate insiders.
Wall Street Analysts Forecast Growth
Several analysts have issued reports on UNH shares. Oppenheimer boosted their target price on UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. Bank of America reduced their price objective on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday, October 16th. KeyCorp restated an “overweight” rating and issued a $650.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Truist Financial lowered their target price on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Finally, UBS Group dropped their price target on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. One research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, UnitedHealth Group presently has an average rating of “Buy” and a consensus target price of $629.32.
Check Out Our Latest Research Report on UNH
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Further Reading
- Five stocks we like better than UnitedHealth Group
- Insider Selling Explained: Can it Inform Your Investing Choices?
- 3 Unsung Beneficiaries of the Stargate Project
- Short Selling: How to Short a Stock
- Starbucks’ CEO-Led Turnaround Gains Traction: New Highs Likely
- 3 Tickers Leading a Meme Stock Revival
- 3 Chemical Stocks Defying Tariff Worries With Growth Potential
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.